ConMed Orthopedics Burdened by Aging Capital Products and Sales Force Inefficiency

ConMed reported 4Q19 orthopedic revenue of USD $123.8 million, -0.8% vs. 4Q18, with full-year 2019 revenue of $463.3 million, +3.7% vs. 2018. An aging capital product portfolio and difficult quarterly comparison caused the company’s orthopedics business to backslide in 4Q19. Approximately 30% of ConMed’s orthopedics revenue is generated...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us